Bexson Biomedical announced today that it appointed Sheldon Moberg as its new senior vice president of drug delivery. Santa Barbara, Calif.–based Bexson said in a news release that Moberg will lead the development of its drug delivery technologies, starting with a wearable infusion device for its BB106 therapy developed in partnership with Stevanato Group. Get the […]
Pain Management
FDA clears Neurolief’s noninvasive neuromod tech to treat migraines
Neurolief today announced that it received FDA clearance for its Relivion noninvasive neuromodulation system to treat migraines. The noninvasive, multi-channel brain neuromodulation system’s creators designed it to treat acute migraines from home. It is a headset that administers personalized care to patients by delivering stimulation to six branches of the occipital and trigeminal nerves through […]
Nevro posts Street-beating Q4 results
Nevro (NYSE:NVRO) posted fourth-quarter results that beat the consensus forecast on Wall Street as it issued 2021 guidance that was slightly below analysts’ expectations. The Redwood City, Calif.–based spinal cord stimulation system maker reported a loss of –$7.2 million, or –21¢ per share, on sales of $109.7 million for the three months ended Dec. 31, 2020, […]
B. Braun Medical appoints new CFO
B. Braun Medical announced today that it appointed James Allen as a senior VP and as the company’s chief financial officer. Allen, a veteran of more than 30 years in finance and management within multiple industries and disciplines, will replace Bruce Heugel, who last year announced that he would retire after more than 20 years […]
AmacaThera raises $10.3M in oversubscribed Series A
AmacaThera announced today that it completed an oversubscribed $10.3 million Series A financing round. Lumira Ventures led the Series A funding, with existing investors Viva BioInnovator and Sprout BioVentures contributing as well. New investors BDC Capital Women in Technology Venture Fund, Inveready, MBX Capital, CR Capital Management, StandUp Ventures and MaRS IAF participated, too, according to […]
Mainstay Medical raises $108M
Neurostimulation technology developer Mainstay Medical announced that it closed an equity financing worth gross proceeds of $108 million. Dublin, Ireland-based Mainstay said in a news release that it plans to use the funds for the commercial launch of the ReActiv8 system in the U.S., along with continued expansion in Europe and Australia, plus post-market clinical […]
Stryker sells T/Pump product line to C2Dx
C2Dx today announced that it has acquired Stryker’s T/Pump product line for an undisclosed amount. The T/Pump product line provides localized temperature therapy for pain relief and patient comfort. It is used for orthopedic conditions, acute injuries, chronic pain and muscle strains. It can also be used for skin trauma, burns, contusions and other localized […]
NeuroMetrix slides on Q4 losses
NeuroMetrix (NSDQ:NURO) shares dipped today on fourth-quarter results that showcased losses despite an improved bottom line. The Woburn, Mass.-based company posted losses of -$325,767 on sales of $1.8 million for the three months ended Dec. 31, 2020, for a 69.2% bottom-line gain on sales growth of 6%. NeuroMetrix experienced headwinds from the COVID-19 pandemic and felt […]
FDA clears Theranica device for adolescent migraines
Theranica announced today that the FDA has granted expanded clearance for the use of its Nerivio acute migraine treatment device by people 12 years and older. The use of the device in the treatment of adolescents is supported by a study recently published in Headache. According to the study, 28 of 39 (71%) of the adolescent participants using […]
Boston Scientific launches WaveWriter Alpha spinal cord stim
Boston Scientific (NYSE:BSX) today said it launched its WaveWriter Alpha spinal cord stimulator systems in the U.S. The systems are designed to deliver paresthesia-free pain relief in minutes. They are designed with Boston Scientific’s Fast-Acting Sub-perception Therapy (FAST) and have four MRI conditional, Bluetooth-enabled, rechargeable and non-rechargeable implantable pulse generators. “We have found that the specific […]
NeuroOne Medical appoints new CFO
NeuroOne Medical Technologies (OTC:NMTC) announced today that it appointed Ronald McClurg as its chief financial officer. McClurg, a veteran of 30 years in the space of financial leadership, has held the role of CFO for companies including Orthomet, Incisive Surgical, Video Sentry and Insignia Systems, having begun his career in public accounting at Ernst and […]